Fig. 2From: Consistent use of lipid lowering therapy in HIV infection is associated with low mortalityWeighted Survival Curves (all-cause mortality) for ongoing current LLT use (≥3/4 last weeks) by ASCVD status. X-axis: Years after initial HIV suppression, Y-axis: proportion survivingBack to article page